11β-Hydroxysteroid dehydrogenase in cultured human vascular cells: Possible role in the development of hypertension

Hypertension

Volumn 33, Issue 5, 1999, Pages 1179-1184

  Hatakeyama, Haruhiko ^a   Inaba, Satoru ^b   Miyamori, Isamu ^b  

^a UNIVERSITY OF FUKUI   (Japan)

^b NONE

Author keywords

11 hydroxysteroid dehydrogenase; Cortisol; Hypertension, essential; Receptors, angiotensin II; Vascular tone

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; ALDOSTERONE RECEPTOR; ANGIOTENSIN 2 RECEPTOR; COMPLEMENTARY DNA; HORMONE ANTAGONIST; HYDROCORTISONE; MINERALOCORTICOID; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR; CORTICOSTERONE; HYDROXYSTEROID DEHYDROGENASE; MESSENGER RNA; PRIMER DNA;

ARTICLE; BLOOD VESSEL TONE; CONTROLLED STUDY; ENZYME ACTIVITY; ESSENTIAL HYPERTENSION; GENE EXPRESSION; HORMONE RECEPTOR INTERACTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; VASCULAR SMOOTH MUSCLE; CELL CULTURE; COMPARATIVE STUDY; CORONARY BLOOD VESSEL; CYTOLOGY; ENZYMOLOGY; GENETICS; HYPERTENSION; METABOLISM; MOLECULAR GENETICS; MUSCLE TONE; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; PHYSIOLOGY; THIN LAYER CHROMATOGRAPHY;

11-BETA-HYDROXYSTEROID DEHYDROGENASES; ANGIOTENSIN II; BASE SEQUENCE; CELLS, CULTURED; CHROMATOGRAPHY, THIN LAYER; CORONARY VESSELS; CORTICOSTERONE; DNA PRIMERS; GENE EXPRESSION; HUMANS; HYDROCORTISONE; HYDROXYSTEROID DEHYDROGENASES; HYPERTENSION; MOLECULAR SEQUENCE DATA; MUSCLE TONUS; MUSCLE, SMOOTH, VASCULAR; RECEPTORS, ANGIOTENSIN; RNA, MESSENGER;

EID: 0032588828     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.33.5.1179     Document Type: Article

References (41)

1. Kornel L, Ramsay C, Kanamarlapudi N, Travers T, Packer W. Evidence for the presence in arterial walls of intracellular-molecular mechanism for action of mineralocorticoids. Clin Exp Hypertens. 1982;4:1561-1582.
2. Couture R, Regoli D. Vascular reactivity to angiotensin and noradrenalin in rats maintained on a sodium free diet or made hypertensive with deoxycorticosterone acetate and salt. Clin Exp Hypertens. 1980;2:25-43.
3. Sato A, Suzuki H, Murakami M, Nakazato Y, Awaita Y, Saruta T. Glucocorticoid increases angiotensin II type I receptor and its gene expression. Hypertension. 1994;23:25-30.
4. Hatakeyama H, Miyamori I, Fujita T, Takeda Y, Takeda R, Yamamoto H. Vascular aldosterone: biosynthesis and a link to angiotensin II-induced hypertrophy of vascular smooth muscle cells. J Biol Chem. 1994;269: 24316-24320.
5. Takeda Y, Miyamori I, Yoneda T, Iki K, Hatakeyama H, Blair IA, Hsieh FY, Takeda R. Synthesis of corticosterone in the vascular wall. Endocrinology. 1994;135:2283-2286.
6. Takeda Y, Miyamori I, Yoneda T, Iki K, Hatakeyama H, Blair IA, Hsieh FY, Takeda R. Production of aldosterone in isolated rat blood vessels. Hypertension. 1995;25:170-173.
7. Hatakeyama H, Miyamori I, Takeda Y, Yamamoto H, Mabuchi H. The expression of steroidogenic enzyme genes in human vascular cells. Biochem Mol Biol Int. 1996;40:639-645.
8. Takeda Y, Miyamori I, Inaba S, Furukawa K, Hatakeyama H, Yoneda T, Mabuchi H, Takeda R. Vascular aldosterone in genetically hypertensive rats. Hypertension. 1997;29:45-48.
9. Arriza JL, Weinberger C, Cerelli G, Glaser TM, Handelin BL, Housman DE, Evans RM. Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor. Science. 1987;237:268-275.
10. Edwards CRW, Stewart PM, Burt D, Brett L, McIntyre MA, Sutanto WS, DeKloet ER, Monder C. Localisation of 11 beta-hydroxysteroid dehydrogenase-tissue specific protector of the mineralocorticoid receptor. Lancet. 1988;2:986-989.
11. Funder JW, Pearce PT, Smith R, Smith AI. Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated. Science. 1988; 242:583-585.
12. Tannin GM, Agarwal AK, Monder C, New MI, White PC. The human gene for 11β-hydroxysteroid dehydrogenase: structure, tissue distribution, and chromosomal localization. J Biol Chem. 1991;266: 16653-16658.
13. Whorwood CB, Mason JI, Ricketts ML, Howie AJ, Stewart PM. Detection of human 11β-hydroxysteroid dehydrogenase isoforms using reverse-transcriptase-polymerase chain reaction and localization of the type 2 isoform to renal collecting ducts. Mol Cell Endocrinol. 1995;110: R7-R12.
14. Stewart PM, Valentino R, Wallace AM, Burt D, Shackleton CHL, Edwards CRW. Mineralocorticoid activity of liquorice: 11beta-hydroxysteroid dehydrogenase deficiency comes of age. Lancet. 1987;2: 821-823.
15. Mune T, Rogerson FM, Nikkila H, Agarwal AK, White PC. Human hypertension caused by mutations in the kidney isozyme of 11β-hydroxysteroid dehydrogenase. Nat Genet. 1995;10:394-399.
16. Nikkila H, Tannin GM, New MI, Taylor NF, Kalaitzoglou G, Monder C, White PC. Defects in the HSD11 gene encoding 11β-hydroxysteroid dehydrogenase are not found in patients with apparent mineralocorticoid excess or 11-oxoreductase deficiency. J Clin Endocrinol Metab. 1993; 77:687-691.
17. Soro A, Ingram MC, Tonolo G, Glorioso N, Fraser R. Evidence of coexisting changes in 11β-hydroxysteroid dehydrogenase and 5ß-reductase activity in subjects with untreated essential hypertension. Hypertension. 1995;25:67-70.
18. Takeda Y, Miyamori I, Iki K, Inaba S. Furukawa K, Hatakeyama H, Yoneda T, Takeda R. Endogenous renal 11β-hydroxysteroid dehydrogenase inhibitory factors in patients with low-renin essential hypertension. Hypertension. 1996;27:197-201.
19. Takeda Y, Miyamori I, Yoneda T. Hatakeyama H, Iki K, Takeda R. Decreased activity of 11β-hydroxysteroid dehydrogenase in mesenteric arteries of Dahl salt-sensitive rats. Life Sci. 1994;54:1343-1349.
20. Takeda Y, Miyamori I, Yoneda T, Iki K, Hatakeyama H, Takeda R. Gene expression of 11β-hydroxysteroid dehydrogenase in the mesenteric arteries of genetically hypertensive rats. Hypertension. 1994;23:577-580.
21. Albiston AL, Obeyesekere VR, Smith RE, Krozowski ZS. Cloning and tissue distribution of the human 11β-hydroxysteroid dehydrogenase type 2 enzyme. Mol Cell Endocrinol. 1994;105:R11-R17.
22. Kawakami K, Ohta T, Nojima H, Nagano K. Primary structure of the alpha-subunit of human Na, K-ATPase deduced from cDNA sequence. J Biochem (Tokyo). 1986;100:389-397.
23. Brem AS, Bina RB, King T, Morris DJ. Bidirectional activity of 11β-hydroxysteroid dehydrogenase in vascular smooth muscle cells. Steroids. 1995;60:406-410.
24. Michael AE, Gregory L, Thaventhiran L, Antoniw JW, Cooke BA. Follicular variation in ovarian 11β-hydroxysteroid dehydrogenase J (11β-HSD) activities: evidence for the paracrine inhibition of 11β-HSD in human granulosa-lutein cells. J Endocrinol. 1996;148:419-425.
25. Yang K, Yu M. Evidence for distinct isoforms of 11β-hydroxysteroid dehydrogenase in the ovine liver and kidney. J Steroid Biochem Mol Biol. 1994;49:245-250.
26. Agarwal AK, Rogerson FM, Mune T, White PC. Gene structure and chromosomal localization of the human HSD11K gene encoding the kidney (type 2) isozyme of 11β-hydroxysteroid dehydrogenase. Genomics. 1995;29:195-199.
27. Takayanagi R, Ohnaka K, Sakai Y, Nakao R, Yanase T, Haji M, Inagami T, Furuta H, Gou DF, Nakamura M, Nawata H. Molecular cloning, sequence analysis and expression of a cDNA encoding human type-1 angiotensin II receptor. Biochem Biophys Res Commun. 1992;183: 910-916.
28. Ullian ME, Schelling JR, Linas SL. Aldosterone enhances angiotensin II receptor binding and inositol phosphate responses. Hypertension. 1992; 20:67-73.
29. Walker BR, Yau JL, Brett LP, Seckl JR, Monder C, Williams BC, Edwards CRW. 11β-Hydroxysteroid dehydrogenase in vascular smooth muscle and heart: implications for cardiovascular responses to glucocorticoids. Endocrinology. 1991;129:3305-3312.
30. Duperrex H, Kenouch S, Gaeggeler HP, Seckl JR, Edwards CRW, Farman N, Rossier BC. Rat liver 11 beta-hydroxysteroid dehydrogenase complementary deoxyribonucleic acid encodes oxoreductase activity in a mineralocorticoid-responsive toad bladder cell line. Endocrinology. 1993; 132:612-619.
31. Rakugi H, Jacob HJ, Krieger JE, Ingelfinger JR, Pratt RE. Vascular injury induces angiotensinogen gene expression in the media and neointima. Circulation. 1993;87:283-290.
32. Ip JH, Fuster V, Badimon L, Badimon J, Taubman MB, Chesebro JH. Syndromes of accelerated atherosclerosis: role of vascular injury and smooth muscle cell proliferation. J Am Coll Cardiol. 1990;15:1667-1687.
33. Schiffrin EL, Gutkowska J, Genest J. Effect of angiotensin II and deoxycorticosterone infusion on vascular angiotensin II receptors in rats. Am J Physiol. 1984;246:H608-H614.
34. Schiffrin EL, Franks DJ, Gutkowska J. Effect of aldosterone on vascular angiotensin II receptors in the rats. Can J Physiol Pharmacol. 1985;63: 1522-1527.
35. Monder C, Stewart PM, Lakshmi V, Valentino R, Burt D, Edwards CRW. Licorice inhibits corticosterone 11β-dehydrogenase of rat kidney and liver: in vivo and in vitro studies. Endocrinology. 1989;125:1046-1053.
36. Brem AS, Bina RB, King TC, Morris DJ. Localization of 2 11β-OH 1 steroid dehydrogenase isoforms in aortic endothelial cells. Hypertension. 1998;31:459-462.
37. Brem AS, Bina RB, Hill N, Alia C, Morris DJ. Effects of licorice derivatives on vascular smooth muscle function. Life Sci. 1997;60: 207-214.
38. Stewart PM, Whorwood CB, Valentino R, Burt D, Sheppard MC, Edwards CRW. 11-Beta-hydroxysteroid dehydrogenase activity and gene expression in the hypertensive Bianchi-Milan rat. J Hypertens. 1993;11: 349-354.
39. Farese RV, Biglieri EG, Shackleton CHL, Irony I, Gomez-Fontes R. Licorice-induced hypermineralocorticoism. N Engl J Med. 1991;325: 1223-1227.
40. Fraser R, Davies DL, Connell JMC. Hormones and hypertension. Clin Endocrinol (Oxf). 1989;31:701-746.
41. Handa M, Kondo K, Suzuki H, Saruta T. Dexamethasone hypertension in rats: role of prostaglandins and pressor sensitivity to norepinephrine. Hypertension. 1984;6:236-241.